Lisinopril effects on kidney function
Pro Research Analysisby 
Searched over 200M research papers
Lisinopril and Kidney Function: Effects in Diabetic Nephropathy and Hypertension
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is widely used to manage hypertension and protect kidney function, especially in patients with diabetes and proteinuric kidney diseases.
Lisinopril’s Impact on Albuminuria and Glomerular Filtration Rate (GFR) in Diabetic Nephropathy
In patients with diabetic nephropathy, lisinopril significantly reduces albuminuria compared to other antihypertensive agents like atenolol, even when blood pressure reduction is similar. Studies show that lisinopril can reduce albuminuria by 45–55%, while atenolol achieves only a 12–15% reduction, indicating a stronger effect of lisinopril on kidney protection in this context Nielsen1994Nielsen1997. However, the rate of decline in GFR over time is similar between lisinopril and atenolol, suggesting that while lisinopril is more effective at reducing protein loss in urine, both drugs slow the progression of kidney dysfunction to a similar degree Nielsen1994Nielsen1997.
Long-Term Renal Protection: Lisinopril vs. Other Antihypertensives
When compared to calcium channel blockers like nisoldipine in type 1 diabetic patients, lisinopril leads to a significant reduction in albuminuria, but both drugs show similar long-term effects on the decline of GFR. This suggests that lisinopril’s main benefit may be in reducing proteinuria rather than in halting the overall decline in kidney function over several years .
Lisinopril in Renal Transplant Recipients
In kidney transplant patients with hypertension and proteinuria, lisinopril effectively lowers blood pressure and proteinuria without causing significant changes in serum creatinine or GFR over a short-term period. It also reduces renal vascular resistance and increases renal plasma flow, indicating improved kidney blood flow . However, over a longer period (two years), another study found that nifedipine, a calcium channel blocker, led to greater improvements in GFR compared to lisinopril, though both drugs were safe and effective for blood pressure control .
Genetic and Experimental Insights: APOL1 Variants and Acute Kidney Injury
Experimental models show that lisinopril can dramatically reduce proteinuria and kidney scarring in certain genetic backgrounds (APOL1 G1 variant), but higher doses are needed and benefits are less pronounced in others (APOL1 G2 variant). This suggests that genetic factors may influence how well lisinopril protects the kidneys .
In animal models of acute kidney injury, lisinopril also reduces markers of kidney damage, oxidative stress, and inflammation, supporting its protective role in various types of kidney injury .
Lisinopril in Chronic Hepatitis-Related Renal Dysfunction
In patients with chronic hepatitis and associated kidney dysfunction, lisinopril improves kidney filtration and increases urine output, especially under stress conditions like water loading. This indicates that lisinopril can enhance the adaptive function of the kidneys in settings beyond diabetes and transplantation Kvasnytska2023Rykalo2019.
Influence of Genetic Polymorphisms
The effectiveness of lisinopril in slowing the progression of kidney disease may be influenced by genetic factors such as the ACE gene insertion/deletion polymorphism. Patients with the II genotype experience the greatest reduction in albumin excretion with lisinopril, while those with the DD genotype see less benefit, highlighting the potential for personalized treatment approaches .
Conclusion
Lisinopril consistently reduces proteinuria and improves certain aspects of kidney function across a range of conditions, including diabetic nephropathy, kidney transplantation, and chronic hepatitis-related renal dysfunction. While its effect on slowing GFR decline is often similar to other antihypertensive agents, its superior ability to reduce proteinuria and improve renal hemodynamics makes it a valuable option for kidney protection. Genetic factors and the underlying cause of kidney disease may influence the degree of benefit seen with lisinopril, suggesting the importance of individualized therapy.
Sources and full results
Most relevant research papers on this topic